BIONIK LABORATORIES CORP. Forms 3, 4 and 5: Corporate Securities (Bonds and Notes)
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-06-13: Reporting owner AUBERTON-HERVE ANDRE-JACQUES; Form 4; Security Convertible Promissory Note; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | AUBERTON-HERVE ANDRE-JACQUES Director | 4 | Convertible Promissory Note Derivative · Indirect · Through Star SCI | P Open market or private purchase of non-derivative or derivative security | +1 1 owned after | $220,000.00 | 2023-06-21 |